Euclid Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-5,160
| Closed | -$602K | – | 492 |
|
|
2016
Q2 | $602K | Sell |
5,160
-2,437
| -32% | -$284K | 0.03% | 365 |
|
|
2016
Q1 | $1.06M | Sell |
7,597
-12,227
| -62% | -$1.7M | 0.04% | 332 |
|
|
2015
Q4 | $3.78M | Buy |
+19,824
| New | +$3.78M | 0.12% | 217 |
|
|
2015
Q3 | – | Sell |
-33,347
| Closed | -$6.03M | – | 460 |
|
|
2015
Q2 | $6.03M | Sell |
33,347
-39,963
| -55% | -$7.22M | 0.12% | 220 |
|
|
2015
Q1 | $12.7M | Buy |
+73,310
| New | +$12.7M | 0.23% | 90 |
|
|
2014
Q4 | – | Sell |
-100,840
| Closed | -$16.7M | – | 520 |
|
|
2014
Q3 | $16.7M | Buy |
100,840
+6,160
| +7% | +$1.02M | 0.12% | 166 |
|
|
2014
Q2 | $14.8M | Sell |
94,680
-14,514
| -13% | -$2.27M | 0.1% | 197 |
|
|
2014
Q1 | $16.6M | Buy |
109,194
+31,010
| +40% | +$4.72M | 0.13% | 160 |
|
|
2013
Q4 | $10.4M | Sell |
78,184
-3,656
| -4% | -$486K | 0.09% | 226 |
|
|
2013
Q3 | $9.51M | Buy |
81,840
+16,674
| +26% | +$1.94M | 0.1% | 207 |
|
|
2013
Q2 | $6.01M | Buy |
+65,166
| New | +$6.01M | 0.08% | 265 |
|